CTY

20.36010.95%
ST

Sebastian Trousil

Co-Founder & COO

Mr. Sebastian Trousil, Ph.D., is Co-Founder of City Therapeutics, Inc. and serves as its Chief Operating Officer since September 2023 and served as its Secretary. Mr. Trousil is a Principal at RTW Investments, LP. He is responsible for conceptualizing, forming and building best-in-class new ventures originated by RTW. He had served as a Senior associate at Flagship Pioneering since 2019 until 2021. Mr. Sebastian Trousil served as an Associate at Flagship Pioneering since Oct 2017 till 2019. He was working as part of a team of entrepreneurial scientists to conceive, create, resource and develop the next generation of Flagship's first-in-category startups, as well as to fund promising early-stage companies. He served as a VentureLabs Fellow in the year between Jun 2017 to Aug 2017. He joined the firm after completing the firm's Fellows program. Before joining Flagship, Sebastian completed postdoctoral research as a fellow in the laboratory of Dr. Bin Zheng at Harvard Medical School and the Massachusetts General Hospital. While at Harvard/MGH, he initiated and led multiple melanoma research projects focusing on novel therapies, therapy resistance, tumor metabolism and immune-oncology. He is the recipient of the prestigious MGH Tosteson Fellowship. Prior to the postdoctoral work, Sebastian completed his Ph.D. in cancer pharmacology at Imperial College London in the laboratory of Dr. Eric Aboagye in the year between 2010 to 2014, where he developed novel cancer drugs and molecular imaging modalities. He studied Master in Research in Translational Medicine from Imperial College London in the year between 2009 to 2010 One molecule he developed at Imperial College London has progressed into clinical trials. Additionally, Sebastian is a founding member of Humon, a tech startup where he designed a wearable muscle oxygen sensor for athletes. Humon has been featured in rechCrunch, WIRED, Runner's World, Forbes and others. He has published more than m publications— including articles in top-tier journals such as Nature Medicine and Molecular Cell—and holds multiple patents. He studied Mini MBA in Strategy, Operations, Finance, Accounting, Economics and Marketing Cource from Harvard Business School in the year 2016. Sebastian holds a Master of Pharmacy degree in pharmacy from the University of Vienna in Austria in the year between 2003 to 2009. He also holds Ph.D. in Pharmacology and Cancer in the year between 2010 to 2014 from Imperial College London. He also holda MRes in Translational Medicine from Imperial College London in the year 2009 to 2010.

Positions